2006
DOI: 10.1016/j.ijpharm.2006.03.031
|View full text |Cite
|
Sign up to set email alerts
|

Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: Potential as buccal delivery system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(15 citation statements)
references
References 20 publications
0
15
0
Order By: Relevance
“…20 The hydrophobic cavity in CDs can partially accommodate low molecular lipophilic drug molecule and polymers. 21 Hydrophilic drug-CD complexes are formed by inclusion of lipophilic drug or lipophilic drug molecule in the central cavity. The lipophilic cavity thus protects the lipophilic guest molecule from aqueous environment, while the outer polar surface of the CD provides the solubilizing effect.…”
Section: Structure Of Cdsmentioning
confidence: 99%
See 1 more Smart Citation
“…20 The hydrophobic cavity in CDs can partially accommodate low molecular lipophilic drug molecule and polymers. 21 Hydrophilic drug-CD complexes are formed by inclusion of lipophilic drug or lipophilic drug molecule in the central cavity. The lipophilic cavity thus protects the lipophilic guest molecule from aqueous environment, while the outer polar surface of the CD provides the solubilizing effect.…”
Section: Structure Of Cdsmentioning
confidence: 99%
“…Cappello et al 21 prepared tablet for the buccal delivery of the poorly soluble drug carvedilol containing poly (ethyleneoxide) as bioadhesive material for sustained-release and hydroxypropyl-β-cyclodextrin as modulator for enhancing drug release. The results confirmed that the prepared hydroxypropyl-β-cyclodextrin containing tablets showed increase in drug dissolution.…”
Section: Figure 1 Depicts the Guest-host Inclusion Complexes Formationmentioning
confidence: 99%
“…It has been shown that carvedilol forms 1:2 drug/cyclodextrin complexes with the natural β-cyclodextrin (βCD; 3). 2-Hydroxypropyl-βCD (HPβCD) and sulfobutylether βCD (SBEβCD) have been used as complexing agent in carvedilol buccal and sustained release tablets (4)(5)(6).…”
Section: Introductionmentioning
confidence: 99%
“…PEO have recently received wide attention as sustained-release bioadhesive platform due to its safety, ease of processing and possibility to control drug release. In medicine, the polymer has been incorporated in several drugs such as oral sustainedrelease tablets [1][2][3][4][5] and ocular inserts. 6 in addition, it has been shown that particles with poly(ethylene oxide) surfaces have great potential as long circulating systems after intravenous administration [7][8][9][10][11] .…”
Section: Introductionmentioning
confidence: 99%